Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemia
Roberta Santos Azevedo,Wei‐Ying Jen,Danielle Hammond,Fadi G. Haddad,Alexis C. Geppner,Ghayas C. Issa,Koji Sasaki,Jayastu Senapati,Elias Jabbour,Farhad Ravandi,Hagop M. Kantarjian,Tapan M. Kadia
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
水煮电吹风
欧克
学术文献互助
Kao
GingerF
唠叨的大门
v0id
无极微光
Criminology34
OK
DOC_XIONG
YifanWang
渡人舟
null
秋风
bingbing
Nole
掐钰
DW
皖公网安备34019202002308
